Correlation Between HELIX BIOPHARMA and SIVERS SEMICONDUCTORS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HELIX BIOPHARMA and SIVERS SEMICONDUCTORS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HELIX BIOPHARMA and SIVERS SEMICONDUCTORS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HELIX BIOPHARMA and SIVERS SEMICONDUCTORS AB, you can compare the effects of market volatilities on HELIX BIOPHARMA and SIVERS SEMICONDUCTORS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HELIX BIOPHARMA with a short position of SIVERS SEMICONDUCTORS. Check out your portfolio center. Please also check ongoing floating volatility patterns of HELIX BIOPHARMA and SIVERS SEMICONDUCTORS.

Diversification Opportunities for HELIX BIOPHARMA and SIVERS SEMICONDUCTORS

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between HELIX and SIVERS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HELIX BIOPHARMA and SIVERS SEMICONDUCTORS AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIVERS SEMICONDUCTORS and HELIX BIOPHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HELIX BIOPHARMA are associated (or correlated) with SIVERS SEMICONDUCTORS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIVERS SEMICONDUCTORS has no effect on the direction of HELIX BIOPHARMA i.e., HELIX BIOPHARMA and SIVERS SEMICONDUCTORS go up and down completely randomly.

Pair Corralation between HELIX BIOPHARMA and SIVERS SEMICONDUCTORS

Assuming the 90 days trading horizon HELIX BIOPHARMA is expected to generate 5.39 times more return on investment than SIVERS SEMICONDUCTORS. However, HELIX BIOPHARMA is 5.39 times more volatile than SIVERS SEMICONDUCTORS AB. It trades about 0.09 of its potential returns per unit of risk. SIVERS SEMICONDUCTORS AB is currently generating about -0.03 per unit of risk. If you would invest  23.00  in HELIX BIOPHARMA on September 1, 2024 and sell it today you would earn a total of  92.00  from holding HELIX BIOPHARMA or generate 400.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HELIX BIOPHARMA  vs.  SIVERS SEMICONDUCTORS AB

 Performance 
       Timeline  
HELIX BIOPHARMA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HELIX BIOPHARMA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, HELIX BIOPHARMA is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
SIVERS SEMICONDUCTORS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SIVERS SEMICONDUCTORS AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

HELIX BIOPHARMA and SIVERS SEMICONDUCTORS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HELIX BIOPHARMA and SIVERS SEMICONDUCTORS

The main advantage of trading using opposite HELIX BIOPHARMA and SIVERS SEMICONDUCTORS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HELIX BIOPHARMA position performs unexpectedly, SIVERS SEMICONDUCTORS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIVERS SEMICONDUCTORS will offset losses from the drop in SIVERS SEMICONDUCTORS's long position.
The idea behind HELIX BIOPHARMA and SIVERS SEMICONDUCTORS AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.